$71.82
1.74%
NYSE, Sep 02, 10:00 pm CET
ISIN
US83444M1018
Symbol
SOLV

Solventum Stock price

$71.82
-1.40 1.91% 1M
-8.34 10.40% 6M
+5.76 8.72% YTD
+7.71 12.03% 1Y
-8.18 10.23% 3Y
-8.18 10.23% 5Y
-8.18 10.23% 10Y
-8.18 10.23% 20Y
NYSE, Closing price Tue, Sep 02 2025
-1.27 1.74%
ISIN
US83444M1018
Symbol
SOLV
Index

Key metrics

Basic
Market capitalization
$12.5b
Enterprise Value
$19.8b
Net debt
$7.3b
Cash
$492.0m
Shares outstanding
173.4m
Valuation (TTM | estimate)
P/E
32.9 | 12.0
P/S
1.5 | 1.4
EV/Sales
2.4 | 2.3
EV/FCF
136.4
P/B
3.4
Financial Health
Equity Ratio
20.5%
Return on Equity
16.2%
ROCE
6.5%
ROIC
7.6%
Debt/Equity
2.1
Financials (TTM | estimate)
Revenue
$8.4b | $8.7b
EBITDA
$1.3b | $2.0b
EBIT
$810.0m | $1.7b
Net Income
$380.0m | $1.0b
Free Cash Flow
$145.0m
Growth (TTM | estimate)
Revenue
2.2% | 5.1%
EBITDA
-35.7% | 23.6%
EBIT
-47.2% | 56.8%
Net Income
-64.1% | 117.2%
Free Cash Flow
-90.5%
Margin (TTM | estimate)
Gross
54.7%
EBITDA
16.0% | 23.6%
EBIT
9.7%
Net
4.5% | 12.0%
Free Cash Flow
1.7%
More
EPS
$2.2
FCF per Share
$0.8
Short interest
2.8%
Employees
-
Rev per Employee
-
Show more

Is Solventum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Solventum Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Solventum forecast:

10x Buy
53%
8x Hold
42%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Solventum forecast:

Buy
53%
Hold
42%
Sell
5%

Financial data from Solventum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
8,388 8,388
2% 2%
100%
- Direct Costs 3,804 3,804
8% 8%
45%
4,584 4,584
2% 2%
55%
- Selling and Administrative Expenses 3,016 3,016
27% 27%
36%
- Research and Development Expense 758 758
0% 0%
9%
1,344 1,344
36% 36%
16%
- Depreciation and Amortization 534 534
4% 4%
6%
EBIT (Operating Income) EBIT 810 810
47% 47%
10%
Net Profit 380 380
64% 64%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Solventum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Solventum Stock News

Neutral
PRNewsWire
one day ago
Accelerates Solventum's business transformation to deliver long-term shareholder value Net proceeds will be used primarily to pay down debt ST. PAUL, Minn.
Neutral
Business Wire
one day ago
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher's Filtration and Separation business...
Neutral
PRNewsWire
6 days ago
ST. PAUL, Minn. , Aug. 28, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences: 2025 Wells Fargo Healthcare Conference in Boston, Mass.
More Solventum News

Company Profile

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Head office United States
CEO Bryan Hanson
Website www.solventum.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today